NCT00402909 Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone Status COMPLETED Phase PHASE4
NCT00399204 Comparison of Cardiovascular Outcomes of Pioglitazone and Metformin in Type 2 Diabetes Patients Status WITHDRAWN Phase PHASE4
NCT00398853 Effect of Chromium Picolinate on Insulin Sensitivity in Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00398060 GOAL Life-Style Change Intervention to Prevent Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00392678 Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D) Status COMPLETED Phase PHASE2/PHASE3
NCT00381186 Impact of 3-year Lifestyle Intervention on Postprandial Glucose Metabolism: the SLIM Study Status COMPLETED Phase NA
NCT00376181 Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus Status TERMINATED Phase PHASE3
NCT00374907 A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise Status COMPLETED Phase PHASE3
NCT00371982 Effect of Fish Oil on Adiposity and Atherogenic Factors in Type 2 Diabetic Women Status TERMINATED Phase NA
NCT00371306 Comparison of Glucovance to Insulin for Diabetes During Pregnancy Status UNKNOWN Phase NA
NCT00366301 The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 Diabetes Status TERMINATED Phase PHASE4
NCT00365495 Influence of Physical Training on Mitochondrial Function in Type 2 Diabetic Patients Status UNKNOWN Phase NA